Physician

Denes Korpas, MD

According to 2025 Medicare claims, Denes Korpas, MD (NPI: 1902992399) practices interventional cardiology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CARDIOVASCULAR CLINIC OF NEBRASKA (NPI: 1346731759; TIN: 823620404) and primary practice location at 68506-2858. Korpas is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Korpas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,677 traditional Medicare patients, billed 9,573 HCPCS/CPT codes, and received $509,684 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,729 prescription claims across 1,073 beneficiaries totaling $1,184,534 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 12 claims. Open Payments data shows 74 records totaling $26,965. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $310,418 to $509,684. Similarly, Part D prescription costs have moved sharply higher in recent years, from $304,402 to $1,184,534. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $8,142 to $6,790.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,093	5,543	$310,418
2016	2,000	5,391	$303,090
2017	1,882	5,588	$318,378
2018	1,706	4,602	$322,208
2019	1,286	6,020	$536,639
2020	1,118	5,759	$418,255
2021	1,130	5,667	$432,968
2022	1,351	7,540	$489,218
2023	1,523	8,118	$492,689
2024	1,677	9,573	$509,684

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	642	5,324	$304,402
2016	636	5,591	$328,896
2017	688	5,662	$376,788
2018	822	6,116	$463,773
2019	745	4,978	$466,066
2020	716	4,849	$521,124
2021	750	4,925	$606,852
2022	810	5,011	$668,667
2023	873	5,158	$865,938
2024	1,073	6,729	$1,184,534

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	52	$4,243
2016	N/R	48	$2,589
2017	N/R	118	$2,890
2018	24	163	$5,390
2019	N/R	80	$2,638
2020	N/R	N/R	N/R
2021	N/R	13	$612
2022	N/R	12	$475
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	543	563	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	908	1,551	$76
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	318	920	$19
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	333	869	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	277	343	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	331	14,723	$283,531
Xarelto	Rivaroxaban	219	11,609	$210,439
Camzyos	Mavacamten	22	660	$184,490
Entresto	Sacubitril/Valsartan	124	5,535	$108,232
Repatha Sureclick	Evolocumab	119	4,452	$83,926

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	73	$1,384	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$25,581	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Denes Korpas, MD?

Tedicare shows public-source Medicare data for Denes Korpas, MD (NPI 1902992399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Denes Korpas, MD have ACO affiliation data?

Denes Korpas, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Denes Korpas, MD?

Denes Korpas, MD is linked to CARDIOVASCULAR CLINIC OF NEBRASKA (billing NPI 1346731759) in the available physician profile data.

Does Denes Korpas, MD have Open Payments data?

Denes Korpas, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.